15,277 Shares in GE HealthCare Technologies Inc. $GEHC Purchased by Continuum Advisory LLC

Continuum Advisory LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 15,277 shares of the company’s stock, valued at approximately $1,253,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Empowered Funds LLC increased its position in GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after purchasing an additional 1,665 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in GE HealthCare Technologies during the first quarter worth about $259,000. Cresset Asset Management LLC increased its position in GE HealthCare Technologies by 12.5% during the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after purchasing an additional 865 shares during the last quarter. Jump Financial LLC increased its position in GE HealthCare Technologies by 317.6% during the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock worth $2,084,000 after purchasing an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL increased its position in GE HealthCare Technologies by 8.6% during the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock worth $299,000 after purchasing an additional 320 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 22nd. The shares were acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO James Saccaro purchased 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The shares were acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have acquired 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Trading Up 1.3%

Shares of GEHC stock opened at $64.67 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm has a market cap of $29.42 billion, a PE ratio of 15.47, a price-to-earnings-growth ratio of 1.44 and a beta of 0.74. The company has a 50-day moving average of $66.89 and a two-hundred day moving average of $75.49. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on GEHC. Jefferies Financial Group cut their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. BTIG Research lowered their target price on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Finally, HSBC lowered their target price on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research note on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $80.21.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.